1. Home
  2. AMPH vs CSR Comparison

AMPH vs CSR Comparison

Compare AMPH & CSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$25.25

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo D/B/A Centerspace

CSR

D/B/A Centerspace

HOLD

Current Price

$65.46

Market Cap

965.4M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPH
CSR
Founded
1996
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
965.4M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
AMPH
CSR
Price
$25.25
$65.46
Analyst Decision
Buy
Buy
Analyst Count
6
7
Target Price
$31.00
$70.50
AVG Volume (30 Days)
368.5K
165.1K
Earning Date
11-06-2025
11-03-2025
Dividend Yield
N/A
4.71%
EPS Growth
N/A
N/A
EPS
2.27
1.82
Revenue
$723,305,000.00
$273,450,000.00
Revenue This Year
$1.35
$6.83
Revenue Next Year
$5.10
$3.14
P/E Ratio
$11.14
$35.87
Revenue Growth
N/A
5.72
52 Week Low
$20.39
$52.76
52 Week High
$45.39
$70.77

Technical Indicators

Market Signals
Indicator
AMPH
CSR
Relative Strength Index (RSI) 42.84 56.56
Support Level $25.22 $60.54
Resistance Level $27.84 $66.83
Average True Range (ATR) 0.80 1.82
MACD -0.22 -0.44
Stochastic Oscillator 2.56 65.41

Price Performance

Historical Comparison
AMPH
CSR

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About CSR D/B/A Centerspace

Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.

Share on Social Networks: